Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA detection
- PMID: 35324900
- PMCID: PMC8947081
- DOI: 10.1371/journal.pone.0259610
Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA detection
Abstract
The ongoing SARS-CoV-2 pandemic has necessitated a dramatic increase in our ability to conduct molecular diagnostic tests, as accurate detection of the virus is critical in preventing its spread. However, SARS-CoV-2 variants continue to emerge, with each new variant potentially affecting widely-used nucleic acid amplification diagnostic tests. RT-LAMP has been adopted as a quick, inexpensive diagnostic alternative to RT-qPCR, but as a newer method, has not been studied as thoroughly. Here we interrogate the effect of SARS-CoV-2 sequence mutations on RT-LAMP amplification, creating 523 single point mutation "variants" covering every position of the LAMP primers in 3 SARS-CoV-2 assays and analyzing their effects with over 4,500 RT-LAMP reactions. Remarkably, we observed only minimal effects on amplification speed and no effect on detection sensitivity at positions equivalent to those that significantly impact RT-qPCR assays. We also created primer sets targeting a specific short deletion and observed that LAMP is able to amplify even with a primer containing multiple consecutive mismatched bases, albeit with reduced speed and sensitivity. This highlights RT-LAMP as a robust technique for viral RNA detection that can tolerate most mutations in the primer regions. Additionally, where variant discrimination is desired, we describe the use of molecular beacons to sensitively distinguish and identify variant RNA sequences carrying short deletions. Together these data add to the growing body of knowledge on the utility of RT-LAMP and increase its potential to further our ability to conduct molecular diagnostic tests outside of the traditional clinical laboratory environment.
Conflict of interest statement
New England Biolabs (www.neb.com) has funded this study. All authors (ET, YZ, NT) are employees and shareholders of New England Biolabs, manufacturer of LAMP reagents described in the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures


Similar articles
-
Improving RT-LAMP detection of SARS-CoV-2 RNA through primer set selection and combination.PLoS One. 2022 Apr 1;17(4):e0254324. doi: 10.1371/journal.pone.0254324. eCollection 2022. PLoS One. 2022. PMID: 35363770 Free PMC article.
-
Detection of SARS-CoV-2 RNA using RT-LAMP and molecular beacons.Genome Biol. 2021 Jun 3;22(1):169. doi: 10.1186/s13059-021-02387-y. Genome Biol. 2021. PMID: 34082799 Free PMC article.
-
Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2.Analyst. 2021 Jan 21;146(2):471-477. doi: 10.1039/d0an01775b. Epub 2020 Nov 9. Analyst. 2021. PMID: 33165486
-
Automated sample-to-answer centrifugal microfluidic system for rapid molecular diagnostics of SARS-CoV-2.Lab Chip. 2022 Aug 23;22(17):3157-3171. doi: 10.1039/d2lc00242f. Lab Chip. 2022. PMID: 35670202
-
Advances in RT-LAMP for COVID-19 testing and diagnosis.Expert Rev Mol Diagn. 2023 Jan;23(1):9-28. doi: 10.1080/14737159.2023.2169071. Epub 2023 Mar 1. Expert Rev Mol Diagn. 2023. PMID: 36695788 Review.
Cited by
-
Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers.Anal Biochem. 2024 May;688:115480. doi: 10.1016/j.ab.2024.115480. Epub 2024 Feb 7. Anal Biochem. 2024. PMID: 38331373 Free PMC article.
-
Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures.PLoS One. 2024 Jan 19;19(1):e0296627. doi: 10.1371/journal.pone.0296627. eCollection 2024. PLoS One. 2024. PMID: 38241279 Free PMC article.
-
Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development.BMC Infect Dis. 2025 Jul 1;25(1):861. doi: 10.1186/s12879-025-11227-4. BMC Infect Dis. 2025. PMID: 40596923 Free PMC article.
-
Clinical validation of RCSMS: A rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva.PLoS One. 2024 Mar 25;19(3):e0290466. doi: 10.1371/journal.pone.0290466. eCollection 2024. PLoS One. 2024. PMID: 38527001 Free PMC article.
-
A novel dual probe-based method for mutation detection using isothermal amplification.PLoS One. 2024 Oct 22;19(10):e0309541. doi: 10.1371/journal.pone.0309541. eCollection 2024. PLoS One. 2024. PMID: 39436873 Free PMC article.
References
-
- Artesi M, Bontems S, Gobbels P, Franckh M, Maes P, Boreux R, et al.. A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay. J Clin Microbiol. 2020;58(10). - PMC - PubMed
-
- Amato L, Jurisic L, Puglia I, Di Lollo V, Curini V, Torzi G, et al.. Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR. Emerg Microbes Infect. 2021;10(1):1148–55. doi: 10.1080/22221751.2021.1933609 - DOI - PMC - PubMed
-
- Nakabayashi T, Kawasaki Y, Murashima K, Omi K, Yuhara S. Evaluation of the effects of SARS-CoV-2 genetic mutations on diagnostic RT-PCR assays. bioRxiv. 2021:2021.01.19.426622.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous